Literature DB >> 23758159

Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells.

Zainalabideen Abdulla1, Helen Turley, Kevin Gatter, Francesco Pezzella.   

Abstract

Cyclin D1 immunostaining of non-neoplastic cells has been a source of diagnostic confusion especially in lymphoproliferative lesions. This study has reviewed these in two hundred and thirty-one haematopathological samples stained for cyclin D1. Most cases were formalin-fixed except for a few bone marrow trephines, which were B-5 fixed, and EDTA decalcified. Overall, 94% (216/231) of cases showed one or more types of non-neoplastic cells expressing Cyclin D1 of variable intensity. Endothelial cells and histiocytes were the most commonly identified Cyclin D1 positive cells being positive in 92% (214/231) of cases. Other normal cell types identified included fat cells, stromal fibroblasts, glial cells, spermatocytes, smooth muscle cells, osteoblasts and where present epithelial cells. Many normal cell types can express cyclinD1. Knowledge of these is useful to prevent misinterpretation of cyclin D1 positive tumours.
© 2013 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cyclin D1; endothelial cells; epithelial cells; histiocytes; lymphoid neoplasm

Mesh:

Substances:

Year:  2013        PMID: 23758159     DOI: 10.1111/apm.12123

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection.

Authors:  Narittee Sukswai; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

2.  The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow.

Authors:  Ifeyinwa E Obiorah; Hao-Wei Wang; David Ma; Eddie Martin; Wyndham H Wilson; Raul Braylan
Journal:  Am J Clin Pathol       Date:  2022-05-04       Impact factor: 5.400

3.  Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

Authors:  Takayuki Murase; Masaki Ri; Tomoko Narita; Keiichiro Fujii; Ayako Masaki; Shinsuke Iida; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2019-07-11       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.